ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 60 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $62,000 | -53.0% | 60,400 | -36.9% | 0.00% | – |
Q2 2021 | $132,000 | -23.7% | 95,700 | -5.9% | 0.00% | – |
Q1 2021 | $173,000 | +16.1% | 101,725 | +77.8% | 0.00% | – |
Q4 2016 | $149,000 | +156.9% | 57,200 | +163.4% | 0.00% | – |
Q2 2016 | $58,000 | -14.7% | 21,718 | -1.4% | 0.00% | – |
Q1 2016 | $68,000 | -69.8% | 22,018 | -62.3% | 0.00% | – |
Q4 2015 | $225,000 | +5.1% | 58,346 | +49.8% | 0.00% | – |
Q3 2014 | $214,000 | -46.4% | 38,937 | 0.0% | 0.00% | – |
Q2 2014 | $399,000 | -44.4% | 38,937 | -34.8% | 0.00% | – |
Q1 2014 | $717,000 | – | 59,735 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 6,574,060 | $27,874,000 | 1.68% |
SENZAR ASSET MANAGEMENT, LLC | 798,381 | $3,385,000 | 0.58% |
Cormorant Asset Management, LP | 850,000 | $3,604,000 | 0.48% |
Palo Alto Investors LP | 2,135,739 | $9,056,000 | 0.40% |
Opus Point Partners Management, LLC | 99,959 | $424,000 | 0.34% |
Granahan Investment Management | 1,582,237 | $6,709,000 | 0.19% |
Joel Isaacson & Co., LLC | 70,660 | $300,000 | 0.08% |
MARINER INVESTMENT GROUP LLC | 59,700 | $253,000 | 0.06% |
MYCIO WEALTH PARTNERS, LLC | 75,000 | $318,000 | 0.06% |
Cornerstone Capital, Inc. | 59,200 | $251,000 | 0.06% |